Here, we report that disturbed GluR1:GluR2 ratio contributes to CA1 and DG specific pyramidal neuronal loss and hippocampal atrophy, as well as BLA hypertrophy, which are reversed by FWP treatment. The gene discussed is GRIA1; the disease is Atrophy.